The breakthrough marks the country’s entry into advanced gene-editing therapeutics, an area so far dominated by a handful of ...
YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the ...
Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
Setting a new milestone in Atmanirbhar Bharat, the government on Wednesday launched an indigenous CRISPR-based gene therapy ...
CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...
“These results establish the CssDNA process as an efficient non-viral gene insertion strategy, and mark a pivotal advance towards the development of next-generation cell and gene therapies” said ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...
Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.
WYFF News 4 on MSN
Greer, South Carolina, family hosts fundraiser for gene therapy to treat children with rare disorder
A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback